Drugs Health Pharma

Eisai, Biogen to sell Alzheimer’s drug in Japan starting December 20 

HQ Team December 13, 2023: Japan’s Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan.

Read More
Climate Health Pharma

Heatwaves in Japan hit agricultural output, may opt for imports 

HQ Team September 25, 2023: Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to.

Read More
Drugs Health Pharma

Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s 

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.

Read More
Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.

Read More
Climate Health Pharma

Heatwaves across Europe, the US “new normal,” says WMO 

HQ Team August 21, 2023: The heat waves sweeping across the globe are the “new normal” and do not come as a surprise,.

Read More
Drugs Health Pharma

Japan’s radiologists invent AI model to predict age from chest graphs 

HQ Team August 18, 2023: Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect.

Read More
Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

Read More
Drugs Health Pharma

BridgeBio says oral drug to treat rare heart disease meets trial goal

HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.

Read More
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More
Climate Health Pharma

A potential ‘pathogen storm’ is brewing up in the oceans

HQ Team May 22, 2023: A combination of flesh-eating bacteria, brown seaweed, and plastics in the ocean can potentially create a “pathogen storm”.

Read More
X